Found 74 matching trials
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas PHASE1 Objectives:
To determine maximum tolerated dose of farnesyl transferase in...
Show More Location
Duke University Health System
Learn More & Join Trial
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids PHASE2 ARISTOCRAT is a phase II, multi-centre, double-blind, placebo-controlled, r...
Show More Location
Glan Clwyd Hospital
Learn More & Join Trial
Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children PHASE2 This study is a prospective single-center clinical study, which aims to obs...
Show More Location
Beijing Sanbo Brain Hospital
Learn More & Join Trial
Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma PHASE1 Glioblastomas (GBMs) are the most common malignant primary brain tumors. De...
Show More Location
Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol
Learn More & Join Trial
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas PHASE2 This study was conducted to evaluate the efficacy and safety of depatuxizum...
Show More Location
Lucile Packard Children's Hosp /ID# 153678
Learn More & Join Trial
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma PHASE1 This clinical trial is a rollover study designed to provide continued acces...
Show More Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Learn More & Join Trial
Randomised Study to Compare the Efficacy of AZD6244 vs TMZ PHASE2 The primary purpose of this study is to compare the efficacy of AZD6244 (AR...
Show More Learn More & Join Trial
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) PHASE2 MBM-02 (Tempol) is an HIF-1 and HIF-2 inhibitor that is being tested as an ...
Show More Learn More & Join Trial
A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma PHASE1 This clinical study will assess the doses of BKM120 appropriate for patient...
Show More Location
Highlands Oncology Group Highlands Oncology
Learn More & Join Trial
O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors PHASE2 This phase II trial is studying how well giving O6-benzylguanine together w...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial